Observational studyScientific reports2022

Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA).

T Graier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.